TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 54 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,623,000 | +5.2% | 899,092 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,444,000 | -10.6% | 899,092 | +0.3% | 0.00% | 0.0% |
| Q2 2016 | $3,854,000 | -9.6% | 896,369 | -2.6% | 0.00% | 0.0% |
| Q1 2016 | $4,261,000 | -53.7% | 920,408 | +0.4% | 0.00% | -50.0% |
| Q4 2015 | $9,197,000 | +38.7% | 916,927 | +3.1% | 0.00% | +100.0% |
| Q3 2015 | $6,632,000 | -81.6% | 888,999 | +16.7% | 0.00% | -83.3% |
| Q2 2015 | $36,141,000 | +47.5% | 761,828 | +13.9% | 0.01% | +50.0% |
| Q1 2015 | $24,504,000 | +44.3% | 668,779 | +56.4% | 0.00% | +33.3% |
| Q4 2014 | $16,984,000 | +303.5% | 427,711 | +102.7% | 0.00% | +200.0% |
| Q3 2014 | $4,209,000 | +10.4% | 210,959 | -25.3% | 0.00% | 0.0% |
| Q2 2014 | $3,811,000 | -11.8% | 282,508 | -28.8% | 0.00% | 0.0% |
| Q1 2014 | $4,320,000 | +14.1% | 396,654 | +41.7% | 0.00% | 0.0% |
| Q4 2013 | $3,785,000 | +29.3% | 279,987 | +8.8% | 0.00% | 0.0% |
| Q3 2013 | $2,927,000 | +86.0% | 257,227 | +14.9% | 0.00% | – |
| Q2 2013 | $1,574,000 | – | 223,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |